Pharma & Healthcare

Global Oxaliplatin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

The global Oxaliplatin market size was US$ 1063 million in 2024 and is forecast to a readjusted size of US$ 1915 million by 2031 with a CAGR of 8.9% during the forecast period 2025-2031.
Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy the third stage colon cancer after resecting primary tumor completely.

In this report, only the finished drug is covered, exclude API.
Europe is the largest market with about 33% market share. Followed by Japan, accounting for about 30% revenue market share.
The key players are Sanofi-Aventis, Yakult honsha, Dr Reddy"s laboratories, Sun Pharmaceutical, Teva, Fresenius Kabi, Hospira, Mylan, Jiangsu Hengrui Medicine, Nanjing Pharmaceutical Factory, Jiangsu Aosaikang Pharmaceutical, Qilu Pharmaceutical, Hisun Pharmaceutical, Lunan Pharmaceutical, Luoxin, Halfsky Pharmacy, YRPG, Hainan Jinrui Pharmaceutical, Jari Pharmaceutical, Chiatai Tianqing etc. Top 3 companies occupied about 66% revenue market share.
The global Oxaliplatin market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Sanofi-Aventis
Yakult honsha
Dr Reddy's laboratories
Sun Pharmaceutical
Teva
Fresenius Kabi
Hospira
Mylan
Jiangsu Hengrui Medicine
Nanjing Pharmaceutical Factory
Jiangsu Aosaikang Pharmaceutical
Qilu Pharmaceutical
Hisun Pharmaceutical
Lunan Pharmaceutical
Luoxin
Halfsky Pharmacy
YRPG
Hainan Jinrui Pharmaceutical
Jari Pharmaceutical
Chiatai Tianqing
By Type: (Dominant Segment vs High-Margin Innovation)
Mannitol
Glucose Solution
Lactose Solution
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Colorectal Cancer
Stomach Cancer
Ovarian Cancer
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Sanofi-Aventis in Europe)
- Emerging Product Trends: Mannitol adoption vs. Glucose Solution premiumization
- Demand-Side Dynamics: Colorectal Cancer growth in China vs. Stomach Cancer potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
India
Israel
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Oxaliplatin market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Glucose Solution in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Stomach Cancer in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Oxaliplatin value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Mannitol
1.2.3 Glucose Solution
1.2.4 Lactose Solution
1.2.5 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Colorectal Cancer
1.3.3 Stomach Cancer
1.3.4 Ovarian Cancer
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oxaliplatin Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Oxaliplatin Revenue Market Share by Region (2020-2025)
2.4 Global Oxaliplatin Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Oxaliplatin Market Size and Prospective (2020-2031)
2.5.2 Europe Oxaliplatin Market Size and Prospective (2020-2031)
2.5.3 China Oxaliplatin Market Size and Prospective (2020-2031)
2.5.4 Japan Oxaliplatin Market Size and Prospective (2020-2031)
2.5.5 India Oxaliplatin Market Size and Prospective (2020-2031)
2.5.6 Israel Oxaliplatin Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Oxaliplatin Historic Market Size by Type (2020-2025)
3.2 Global Oxaliplatin Forecasted Market Size by Type (2026-2031)
3.3 Different Types Oxaliplatin Representative Players
4 Breakdown Data by Application
4.1 Global Oxaliplatin Historic Market Size by Application (2020-2025)
4.2 Global Oxaliplatin Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Oxaliplatin Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Oxaliplatin Players by Revenue (2020-2025)
5.1.2 Global Oxaliplatin Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Oxaliplatin Revenue
5.4 Global Oxaliplatin Market Concentration Analysis
5.4.1 Global Oxaliplatin Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Oxaliplatin Revenue in 2024
5.5 Global Key Players of Oxaliplatin Head office and Area Served
5.6 Global Key Players of Oxaliplatin, Product and Application
5.7 Global Key Players of Oxaliplatin, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Oxaliplatin Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Oxaliplatin Market Size by Type (2020-2025)
6.1.2.2 North America Oxaliplatin Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Oxaliplatin Market Size by Application (2020-2025)
6.1.3.2 North America Oxaliplatin Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Oxaliplatin Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Oxaliplatin Market Size by Type (2020-2025)
6.2.2.2 Europe Oxaliplatin Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Oxaliplatin Market Size by Application (2020-2025)
6.2.3.2 Europe Oxaliplatin Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Oxaliplatin Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Oxaliplatin Market Size by Type (2020-2025)
6.3.2.2 China Oxaliplatin Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Oxaliplatin Market Size by Application (2020-2025)
6.3.3.2 China Oxaliplatin Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Oxaliplatin Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Oxaliplatin Market Size by Type (2020-2025)
6.4.2.2 Japan Oxaliplatin Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Oxaliplatin Market Size by Application (2020-2025)
6.4.3.2 Japan Oxaliplatin Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 India Market: Players, Segments and Downstream
6.5.1 India Oxaliplatin Revenue by Company (2020-2025)
6.5.2 India Market Size by Type
6.5.2.1 India Oxaliplatin Market Size by Type (2020-2025)
6.5.2.2 India Oxaliplatin Market Share by Type (2020-2025)
6.5.3 India Market Size by Application
6.5.3.1 India Oxaliplatin Market Size by Application (2020-2025)
6.5.3.2 India Oxaliplatin Market Share by Application (2020-2025)
6.5.4 India Market Trend and Opportunities
6.6 Israel Market: Players, Segments and Downstream
6.6.1 Israel Oxaliplatin Revenue by Company (2020-2025)
6.6.2 Israel Market Size by Type
6.6.2.1 Israel Oxaliplatin Market Size by Type (2020-2025)
6.6.2.2 Israel Oxaliplatin Market Share by Type (2020-2025)
6.6.3 Israel Market Size by Application
6.6.3.1 Israel Oxaliplatin Market Size by Application (2020-2025)
6.6.3.2 Israel Oxaliplatin Market Share by Application (2020-2025)
6.6.4 Israel Market Trend and Opportunities
7 Key Players Profiles
7.1 Sanofi-Aventis
7.1.1 Sanofi-Aventis Company Details
7.1.2 Sanofi-Aventis Business Overview
7.1.3 Sanofi-Aventis Oxaliplatin Introduction
7.1.4 Sanofi-Aventis Revenue in Oxaliplatin Business (2020-2025)
7.1.5 Sanofi-Aventis Recent Development
7.2 Yakult honsha
7.2.1 Yakult honsha Company Details
7.2.2 Yakult honsha Business Overview
7.2.3 Yakult honsha Oxaliplatin Introduction
7.2.4 Yakult honsha Revenue in Oxaliplatin Business (2020-2025)
7.2.5 Yakult honsha Recent Development
7.3 Dr Reddy's laboratories
7.3.1 Dr Reddy's laboratories Company Details
7.3.2 Dr Reddy's laboratories Business Overview
7.3.3 Dr Reddy's laboratories Oxaliplatin Introduction
7.3.4 Dr Reddy's laboratories Revenue in Oxaliplatin Business (2020-2025)
7.3.5 Dr Reddy's laboratories Recent Development
7.4 Sun Pharmaceutical
7.4.1 Sun Pharmaceutical Company Details
7.4.2 Sun Pharmaceutical Business Overview
7.4.3 Sun Pharmaceutical Oxaliplatin Introduction
7.4.4 Sun Pharmaceutical Revenue in Oxaliplatin Business (2020-2025)
7.4.5 Sun Pharmaceutical Recent Development
7.5 Teva
7.5.1 Teva Company Details
7.5.2 Teva Business Overview
7.5.3 Teva Oxaliplatin Introduction
7.5.4 Teva Revenue in Oxaliplatin Business (2020-2025)
7.5.5 Teva Recent Development
7.6 Fresenius Kabi
7.6.1 Fresenius Kabi Company Details
7.6.2 Fresenius Kabi Business Overview
7.6.3 Fresenius Kabi Oxaliplatin Introduction
7.6.4 Fresenius Kabi Revenue in Oxaliplatin Business (2020-2025)
7.6.5 Fresenius Kabi Recent Development
7.7 Hospira
7.7.1 Hospira Company Details
7.7.2 Hospira Business Overview
7.7.3 Hospira Oxaliplatin Introduction
7.7.4 Hospira Revenue in Oxaliplatin Business (2020-2025)
7.7.5 Hospira Recent Development
7.8 Mylan
7.8.1 Mylan Company Details
7.8.2 Mylan Business Overview
7.8.3 Mylan Oxaliplatin Introduction
7.8.4 Mylan Revenue in Oxaliplatin Business (2020-2025)
7.8.5 Mylan Recent Development
7.9 Jiangsu Hengrui Medicine
7.9.1 Jiangsu Hengrui Medicine Company Details
7.9.2 Jiangsu Hengrui Medicine Business Overview
7.9.3 Jiangsu Hengrui Medicine Oxaliplatin Introduction
7.9.4 Jiangsu Hengrui Medicine Revenue in Oxaliplatin Business (2020-2025)
7.9.5 Jiangsu Hengrui Medicine Recent Development
7.10 Nanjing Pharmaceutical Factory
7.10.1 Nanjing Pharmaceutical Factory Company Details
7.10.2 Nanjing Pharmaceutical Factory Business Overview
7.10.3 Nanjing Pharmaceutical Factory Oxaliplatin Introduction
7.10.4 Nanjing Pharmaceutical Factory Revenue in Oxaliplatin Business (2020-2025)
7.10.5 Nanjing Pharmaceutical Factory Recent Development
7.11 Jiangsu Aosaikang Pharmaceutical
7.11.1 Jiangsu Aosaikang Pharmaceutical Company Details
7.11.2 Jiangsu Aosaikang Pharmaceutical Business Overview
7.11.3 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Introduction
7.11.4 Jiangsu Aosaikang Pharmaceutical Revenue in Oxaliplatin Business (2020-2025)
7.11.5 Jiangsu Aosaikang Pharmaceutical Recent Development
7.12 Qilu Pharmaceutical
7.12.1 Qilu Pharmaceutical Company Details
7.12.2 Qilu Pharmaceutical Business Overview
7.12.3 Qilu Pharmaceutical Oxaliplatin Introduction
7.12.4 Qilu Pharmaceutical Revenue in Oxaliplatin Business (2020-2025)
7.12.5 Qilu Pharmaceutical Recent Development
7.13 Hisun Pharmaceutical
7.13.1 Hisun Pharmaceutical Company Details
7.13.2 Hisun Pharmaceutical Business Overview
7.13.3 Hisun Pharmaceutical Oxaliplatin Introduction
7.13.4 Hisun Pharmaceutical Revenue in Oxaliplatin Business (2020-2025)
7.13.5 Hisun Pharmaceutical Recent Development
7.14 Lunan Pharmaceutical
7.14.1 Lunan Pharmaceutical Company Details
7.14.2 Lunan Pharmaceutical Business Overview
7.14.3 Lunan Pharmaceutical Oxaliplatin Introduction
7.14.4 Lunan Pharmaceutical Revenue in Oxaliplatin Business (2020-2025)
7.14.5 Lunan Pharmaceutical Recent Development
7.15 Luoxin
7.15.1 Luoxin Company Details
7.15.2 Luoxin Business Overview
7.15.3 Luoxin Oxaliplatin Introduction
7.15.4 Luoxin Revenue in Oxaliplatin Business (2020-2025)
7.15.5 Luoxin Recent Development
7.16 Halfsky Pharmacy
7.16.1 Halfsky Pharmacy Company Details
7.16.2 Halfsky Pharmacy Business Overview
7.16.3 Halfsky Pharmacy Oxaliplatin Introduction
7.16.4 Halfsky Pharmacy Revenue in Oxaliplatin Business (2020-2025)
7.16.5 Halfsky Pharmacy Recent Development
7.17 YRPG
7.17.1 YRPG Company Details
7.17.2 YRPG Business Overview
7.17.3 YRPG Oxaliplatin Introduction
7.17.4 YRPG Revenue in Oxaliplatin Business (2020-2025)
7.17.5 YRPG Recent Development
7.18 Hainan Jinrui Pharmaceutical
7.18.1 Hainan Jinrui Pharmaceutical Company Details
7.18.2 Hainan Jinrui Pharmaceutical Business Overview
7.18.3 Hainan Jinrui Pharmaceutical Oxaliplatin Introduction
7.18.4 Hainan Jinrui Pharmaceutical Revenue in Oxaliplatin Business (2020-2025)
7.18.5 Hainan Jinrui Pharmaceutical Recent Development
7.19 Jari Pharmaceutical
7.19.1 Jari Pharmaceutical Company Details
7.19.2 Jari Pharmaceutical Business Overview
7.19.3 Jari Pharmaceutical Oxaliplatin Introduction
7.19.4 Jari Pharmaceutical Revenue in Oxaliplatin Business (2020-2025)
7.19.5 Jari Pharmaceutical Recent Development
7.20 Chiatai Tianqing
7.20.1 Chiatai Tianqing Company Details
7.20.2 Chiatai Tianqing Business Overview
7.20.3 Chiatai Tianqing Oxaliplatin Introduction
7.20.4 Chiatai Tianqing Revenue in Oxaliplatin Business (2020-2025)
7.20.5 Chiatai Tianqing Recent Development
8 Oxaliplatin Market Dynamics
8.1 Oxaliplatin Industry Trends
8.2 Oxaliplatin Market Drivers
8.3 Oxaliplatin Market Challenges
8.4 Oxaliplatin Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Oxaliplatin Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Oxaliplatin Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Oxaliplatin Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Oxaliplatin Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Oxaliplatin Revenue Share by Region (2020-2025)
Table 6. Global Oxaliplatin Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Oxaliplatin Revenue Share Forecast by Region (2026-2031)
Table 8. Global Oxaliplatin Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Oxaliplatin Revenue Market Share by Type (2020-2025)
Table 10. Global Oxaliplatin Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Oxaliplatin Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Oxaliplatin Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Oxaliplatin Revenue Market Share by Application (2020-2025)
Table 15. Global Oxaliplatin Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Oxaliplatin Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Oxaliplatin Application
Table 18. Global Oxaliplatin Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Oxaliplatin Market Share by Players (2020-2025)
Table 20. Global Top Oxaliplatin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oxaliplatin as of 2024)
Table 21. Ranking of Global Top Oxaliplatin Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Oxaliplatin Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Oxaliplatin, Headquarters and Area Served
Table 24. Global Key Players of Oxaliplatin, Product and Application
Table 25. Global Key Players of Oxaliplatin, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Oxaliplatin Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Oxaliplatin Revenue Market Share by Company (2020-2025)
Table 29. North America Oxaliplatin Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Oxaliplatin Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Oxaliplatin Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Oxaliplatin Revenue Market Share by Company (2020-2025)
Table 33. Europe Oxaliplatin Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Oxaliplatin Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Oxaliplatin Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Oxaliplatin Revenue Market Share by Company (2020-2025)
Table 37. China Oxaliplatin Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Oxaliplatin Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Oxaliplatin Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Oxaliplatin Revenue Market Share by Company (2020-2025)
Table 41. Japan Oxaliplatin Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Oxaliplatin Market Size by Application (2020-2025) & (US$ Million)
Table 43. India Oxaliplatin Revenue by Company (2020-2025) & (US$ Million)
Table 44. India Oxaliplatin Revenue Market Share by Company (2020-2025)
Table 45. India Oxaliplatin Market Size by Type (2020-2025) & (US$ Million)
Table 46. India Oxaliplatin Market Size by Application (2020-2025) & (US$ Million)
Table 47. Israel Oxaliplatin Revenue by Company (2020-2025) & (US$ Million)
Table 48. Israel Oxaliplatin Revenue Market Share by Company (2020-2025)
Table 49. Israel Oxaliplatin Market Size by Type (2020-2025) & (US$ Million)
Table 50. Israel Oxaliplatin Market Size by Application (2020-2025) & (US$ Million)
Table 51. Sanofi-Aventis Company Details
Table 52. Sanofi-Aventis Business Overview
Table 53. Sanofi-Aventis Oxaliplatin Product
Table 54. Sanofi-Aventis Revenue in Oxaliplatin Business (2020-2025) & (US$ Million)
Table 55. Sanofi-Aventis Recent Development
Table 56. Yakult honsha Company Details
Table 57. Yakult honsha Business Overview
Table 58. Yakult honsha Oxaliplatin Product
Table 59. Yakult honsha Revenue in Oxaliplatin Business (2020-2025) & (US$ Million)
Table 60. Yakult honsha Recent Development
Table 61. Dr Reddy's laboratories Company Details
Table 62. Dr Reddy's laboratories Business Overview
Table 63. Dr Reddy's laboratories Oxaliplatin Product
Table 64. Dr Reddy's laboratories Revenue in Oxaliplatin Business (2020-2025) & (US$ Million)
Table 65. Dr Reddy's laboratories Recent Development
Table 66. Sun Pharmaceutical Company Details
Table 67. Sun Pharmaceutical Business Overview
Table 68. Sun Pharmaceutical Oxaliplatin Product
Table 69. Sun Pharmaceutical Revenue in Oxaliplatin Business (2020-2025) & (US$ Million)
Table 70. Sun Pharmaceutical Recent Development
Table 71. Teva Company Details
Table 72. Teva Business Overview
Table 73. Teva Oxaliplatin Product
Table 74. Teva Revenue in Oxaliplatin Business (2020-2025) & (US$ Million)
Table 75. Teva Recent Development
Table 76. Fresenius Kabi Company Details
Table 77. Fresenius Kabi Business Overview
Table 78. Fresenius Kabi Oxaliplatin Product
Table 79. Fresenius Kabi Revenue in Oxaliplatin Business (2020-2025) & (US$ Million)
Table 80. Fresenius Kabi Recent Development
Table 81. Hospira Company Details
Table 82. Hospira Business Overview
Table 83. Hospira Oxaliplatin Product
Table 84. Hospira Revenue in Oxaliplatin Business (2020-2025) & (US$ Million)
Table 85. Hospira Recent Development
Table 86. Mylan Company Details
Table 87. Mylan Business Overview
Table 88. Mylan Oxaliplatin Product
Table 89. Mylan Revenue in Oxaliplatin Business (2020-2025) & (US$ Million)
Table 90. Mylan Recent Development
Table 91. Jiangsu Hengrui Medicine Company Details
Table 92. Jiangsu Hengrui Medicine Business Overview
Table 93. Jiangsu Hengrui Medicine Oxaliplatin Product
Table 94. Jiangsu Hengrui Medicine Revenue in Oxaliplatin Business (2020-2025) & (US$ Million)
Table 95. Jiangsu Hengrui Medicine Recent Development
Table 96. Nanjing Pharmaceutical Factory Company Details
Table 97. Nanjing Pharmaceutical Factory Business Overview
Table 98. Nanjing Pharmaceutical Factory Oxaliplatin Product
Table 99. Nanjing Pharmaceutical Factory Revenue in Oxaliplatin Business (2020-2025) & (US$ Million)
Table 100. Nanjing Pharmaceutical Factory Recent Development
Table 101. Jiangsu Aosaikang Pharmaceutical Company Details
Table 102. Jiangsu Aosaikang Pharmaceutical Business Overview
Table 103. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Product
Table 104. Jiangsu Aosaikang Pharmaceutical Revenue in Oxaliplatin Business (2020-2025) & (US$ Million)
Table 105. Jiangsu Aosaikang Pharmaceutical Recent Development
Table 106. Qilu Pharmaceutical Company Details
Table 107. Qilu Pharmaceutical Business Overview
Table 108. Qilu Pharmaceutical Oxaliplatin Product
Table 109. Qilu Pharmaceutical Revenue in Oxaliplatin Business (2020-2025) & (US$ Million)
Table 110. Qilu Pharmaceutical Recent Development
Table 111. Hisun Pharmaceutical Company Details
Table 112. Hisun Pharmaceutical Business Overview
Table 113. Hisun Pharmaceutical Oxaliplatin Product
Table 114. Hisun Pharmaceutical Revenue in Oxaliplatin Business (2020-2025) & (US$ Million)
Table 115. Hisun Pharmaceutical Recent Development
Table 116. Lunan Pharmaceutical Company Details
Table 117. Lunan Pharmaceutical Business Overview
Table 118. Lunan Pharmaceutical Oxaliplatin Product
Table 119. Lunan Pharmaceutical Revenue in Oxaliplatin Business (2020-2025) & (US$ Million)
Table 120. Lunan Pharmaceutical Recent Development
Table 121. Luoxin Company Details
Table 122. Luoxin Business Overview
Table 123. Luoxin Oxaliplatin Product
Table 124. Luoxin Revenue in Oxaliplatin Business (2020-2025) & (US$ Million)
Table 125. Luoxin Recent Development
Table 126. Halfsky Pharmacy Company Details
Table 127. Halfsky Pharmacy Business Overview
Table 128. Halfsky Pharmacy Oxaliplatin Product
Table 129. Halfsky Pharmacy Revenue in Oxaliplatin Business (2020-2025) & (US$ Million)
Table 130. Halfsky Pharmacy Recent Development
Table 131. YRPG Company Details
Table 132. YRPG Business Overview
Table 133. YRPG Oxaliplatin Product
Table 134. YRPG Revenue in Oxaliplatin Business (2020-2025) & (US$ Million)
Table 135. YRPG Recent Development
Table 136. Hainan Jinrui Pharmaceutical Company Details
Table 137. Hainan Jinrui Pharmaceutical Business Overview
Table 138. Hainan Jinrui Pharmaceutical Oxaliplatin Product
Table 139. Hainan Jinrui Pharmaceutical Revenue in Oxaliplatin Business (2020-2025) & (US$ Million)
Table 140. Hainan Jinrui Pharmaceutical Recent Development
Table 141. Jari Pharmaceutical Company Details
Table 142. Jari Pharmaceutical Business Overview
Table 143. Jari Pharmaceutical Oxaliplatin Product
Table 144. Jari Pharmaceutical Revenue in Oxaliplatin Business (2020-2025) & (US$ Million)
Table 145. Jari Pharmaceutical Recent Development
Table 146. Chiatai Tianqing Company Details
Table 147. Chiatai Tianqing Business Overview
Table 148. Chiatai Tianqing Oxaliplatin Product
Table 149. Chiatai Tianqing Revenue in Oxaliplatin Business (2020-2025) & (US$ Million)
Table 150. Chiatai Tianqing Recent Development
Table 151. Oxaliplatin Market Trends
Table 152. Oxaliplatin Market Drivers
Table 153. Oxaliplatin Market Challenges
Table 154. Oxaliplatin Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources


List of Figures
Figure 1. Oxaliplatin Product Picture
Figure 2. Global Oxaliplatin Market Share by Type: 2024 VS 2031
Figure 3. Mannitol Features
Figure 4. Glucose Solution Features
Figure 5. Lactose Solution Features
Figure 6. Others Features
Figure 7. Global Oxaliplatin Market Share by Application: 2024 VS 2031
Figure 8. Colorectal Cancer
Figure 9. Stomach Cancer
Figure 10. Ovarian Cancer
Figure 11. Others
Figure 12. Oxaliplatin Report Years Considered
Figure 13. Global Oxaliplatin Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Oxaliplatin Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Oxaliplatin Revenue Market Share by Region: 2020 VS 2024
Figure 16. North America Oxaliplatin Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Europe Oxaliplatin Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. China Oxaliplatin Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Japan Oxaliplatin Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. India Oxaliplatin Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Israel Oxaliplatin Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Global Oxaliplatin Market Share by Players in 2024
Figure 23. Global Top Oxaliplatin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oxaliplatin as of 2024)
Figure 24. The Top 10 and 5 Players Market Share by Oxaliplatin Revenue in 2024
Figure 25. North America Oxaliplatin Market Share by Type (2020-2025)
Figure 26. North America Oxaliplatin Market Share by Application (2020-2025)
Figure 27. Europe Oxaliplatin Market Share by Type (2020-2025)
Figure 28. Europe Oxaliplatin Market Share by Application (2020-2025)
Figure 29. China Oxaliplatin Market Share by Type (2020-2025)
Figure 30. China Oxaliplatin Market Share by Application (2020-2025)
Figure 31. Japan Oxaliplatin Market Share by Type (2020-2025)
Figure 32. Japan Oxaliplatin Market Share by Application (2020-2025)
Figure 33. India Oxaliplatin Market Share by Type (2020-2025)
Figure 34. India Oxaliplatin Market Share by Application (2020-2025)
Figure 35. Israel Oxaliplatin Market Share by Type (2020-2025)
Figure 36. Israel Oxaliplatin Market Share by Application (2020-2025)
Figure 37. Sanofi-Aventis Revenue Growth Rate in Oxaliplatin Business (2020-2025)
Figure 38. Yakult honsha Revenue Growth Rate in Oxaliplatin Business (2020-2025)
Figure 39. Dr Reddy's laboratories Revenue Growth Rate in Oxaliplatin Business (2020-2025)
Figure 40. Sun Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2020-2025)
Figure 41. Teva Revenue Growth Rate in Oxaliplatin Business (2020-2025)
Figure 42. Fresenius Kabi Revenue Growth Rate in Oxaliplatin Business (2020-2025)
Figure 43. Hospira Revenue Growth Rate in Oxaliplatin Business (2020-2025)
Figure 44. Mylan Revenue Growth Rate in Oxaliplatin Business (2020-2025)
Figure 45. Jiangsu Hengrui Medicine Revenue Growth Rate in Oxaliplatin Business (2020-2025)
Figure 46. Nanjing Pharmaceutical Factory Revenue Growth Rate in Oxaliplatin Business (2020-2025)
Figure 47. Jiangsu Aosaikang Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2020-2025)
Figure 48. Qilu Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2020-2025)
Figure 49. Hisun Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2020-2025)
Figure 50. Lunan Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2020-2025)
Figure 51. Luoxin Revenue Growth Rate in Oxaliplatin Business (2020-2025)
Figure 52. Halfsky Pharmacy Revenue Growth Rate in Oxaliplatin Business (2020-2025)
Figure 53. YRPG Revenue Growth Rate in Oxaliplatin Business (2020-2025)
Figure 54. Hainan Jinrui Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2020-2025)
Figure 55. Jari Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2020-2025)
Figure 56. Chiatai Tianqing Revenue Growth Rate in Oxaliplatin Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies